UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000062769
Receipt number R000071864
Scientific Title A Study to Investigate Nicotine Pharmacokinetics Following Use of PA in Healthy Adults Who Smoke Combustible Cigarettes
Date of disclosure of the study information 2026/09/11
Last modified on 2026/09/01 17:56:56

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A Study to Investigate Nicotine Pharmacokinetics Following Use of PA in Healthy Adults Who Smoke Combustible Cigarettes

Acronym

A Study to Investigate Nicotine Pharmacokinetics Following Use of PA in Healthy Adults Who Smoke Combustible Cigarettes

Scientific Title

A Study to Investigate Nicotine Pharmacokinetics Following Use of PA in Healthy Adults Who Smoke Combustible Cigarettes

Scientific Title:Acronym

A Study to Investigate Nicotine Pharmacokinetics Following Use of PA in Healthy Adults Who Smoke Combustible Cigarettes

Region

Japan


Condition

Condition

Smokers

Classification by specialty

Not applicable

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The objective of this single-center, randomized, open-label, crossover study is to investigate nicotine pharmacokinetics following use of PA in healthy adults who smoke combustible cigarettes under confined conditions, using combustible cigarettes as comparators.

Basic objectives2

Others

Basic objectives -Others

The objective of this single-center, randomized, open-label, crossover study is to investigate nicotine pharmacokinetics following use of PA in healthy adults who smoke combustible cigarettes under confined conditions, using combustible cigarettes as comparators.

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Plasma nicotine concentration profiles and nicotine pharmacokinetic parameters

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

No treatment

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

4

Purpose of intervention

Prevention

Type of intervention

Food

Interventions/Control_1

[Non-menthol smokers] Use of non-menthol flavor cigarette (Day1) - Use of non-menthol flavor PA (Day2)

Interventions/Control_2

[Non-menthol smokers] Use of non-menthol flavor PA (Day1) - Use of non-menthol flavor cigarette (Day2)

Interventions/Control_3

[Menthol smokers] Use of menthol flavor cigarette (Day1) - Use of menthol flavor PA (Day2)

Interventions/Control_4

[Menthol smokers] Use of menthol flavor PA (Day1) - Use of menthol flavor cigarette (Day2)

Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

21 years-old <=

Age-upper limit

65 years-old >

Gender

Male and Female

Key inclusion criteria

-Individuals who have smoked commercial combustible cigarettes for 1 year or more and have a positive urine cotinine test at screening
-Individuals who are judged by the investigator to be in good health on the basis of the results of clinical assessments performed by the start of the investigation period on Day1
-Individuals who are willing to participate in the study, understand the informed consent document, and provide written or electronic informed consent, etc.

Key exclusion criteria

-Individuals who have regularly used any tobacco products other than commercial combustible cigarettes within 4 weeks prior to Day 1
-Females who are or may be pregnant, or who are lactating
-Individuals who are employees of the tobacco industry or any other parties involved in the study, etc.

Target sample size

40


Research contact person

Name of lead principal investigator

1st name Naoki
Middle name
Last name Miura

Organization

JAPAN TOBACCO INC.

Division name

Scientific and Regulatory Affairs, Tobacco Business

Zip code

105-6927

Address

Kamiyacho Trust tower, 4-1-1, Toranomon, Minato-Ku, Tokyo

TEL

080-8131-5689

Email

naoki.miura@jt.com


Public contact

Name of contact person

1st name Takuya
Middle name
Last name Suzuki

Organization

JAPAN TOBACCO INC.

Division name

Scientific and Regulatory Affairs, Tobacco Business

Zip code

105-6927

Address

Kamiyacho Trust tower, 4-1-1, Toranomon, Minato-Ku, Tokyo

TEL

080-2044-4311

Homepage URL


Email

takuya.a.suzuki@jt.com


Sponsor or person

Institute

JAPAN TOBACCO INC.

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Hakata Clinic Institutional Review Board

Address

6-18, Tenyamachi, hakata-ku, Fukuoka-shi, Fukuoka prefecture

Tel

092-283-7701

Email

hakataclinic-irb@lta-med.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2026 Year 09 Month 11 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2026 Year 08 Month 12 Day

Date of IRB


Anticipated trial start date

2026 Year 09 Month 24 Day

Last follow-up date

2026 Year 11 Month 06 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2026 Year 09 Month 01 Day

Last modified on

2026 Year 09 Month 01 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000071864